Sreekanth Uppuluri

Sreekanth Uppuluri practices at St. Mary's Hospital - Mammography in Kankakee, Illinois.

Sreekanth Uppuluri's NPI, 1881951630, was assigned on April 18, 2012. Sreekanth Uppuluri holds Illinois license 036138712.

Sreekanth Uppuluri's primary practice is St. Mary's Hospital - Mammography, at 500 West Court Street, Kankakee, IL 60901. The practice phone is (815) 937-2465.

Sreekanth Uppuluri's primary practice is St. Mary's Hospital - Mammography in Kankakee, Illinois. Sreekanth Uppuluri is also affiliated with St. Mary's Hospital. The medical group on file is Prime Healthcare Illinois Medical Group. Dmand AI also links Sreekanth Uppuluri to 2 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Sreekanth Uppuluri practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Sreekanth Uppuluri's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Sreekanth Uppuluri is licensed in Illinois.

CMS data shows 751 Medicare services from Sreekanth Uppuluri across 6 procedure codes in 2024, for 277 Medicare patients. Medicare paid $69,743 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 277 Medicare patients who saw Sreekanth Uppuluri in 2024. The largest group is 75 to 84, with 106 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Sreekanth Uppuluri's median patient age at 72, with 50% women.

In 2024, Sreekanth Uppuluri wrote 147 Medicare Part D claims for 91 patients. 86% of them were for generic drugs. CMS names the drug for 35 of them, across 3 drugs with 11 or more claims each, at $6,390 in total drug cost. In 2022, CMS named 12 claims across 1 drug.

Sreekanth Uppuluri accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Sreekanth Uppuluri from 2 drug and device companies in 2016. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $114.